Author

Ding Xuan Ng

Observed names: D Ng, D. Ng

Institution: SingHealth Polyclinics

Observed institutions: Joslin Diabetes Center, Harvard University, SingHealth Polyclinics, ARIAD Pharmaceuticals (United States)

ORCID: 0000-0002-9617-4712

Observed ORCID: 0000-0002-9617-4712

OpenAlex ID: A5032562419

Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in Type I diabetes mellitus

2000 · S. Araki, Y. Makita, et al. · Diabetologia · 34

Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma

2001 · J Guevara, R Keren, et al. · Cochrane Database of Systematic Reviews · 5

Assessing medication adherence in adults with asthma and its effect on rescue therapy for exacerbations

2025 · Yi Ling Eileen Koh, Kian Yong Kenny Chua, et al. · Frontiers in Pharmacology · 4

Resultant greenhouse gases from the use of inhaled corticosteroid based on Global Initiative for Asthma (GINA) guidelines: a primary care used case from Singapore

2025 · Ding Xuan Ng, Mabel Qi He Leow, et al. · npj Primary Care Respiratory Medicine · 2

Carbon emissions from the increasing use of inhaled corticosteroid-LABA medications: a primary care used case from Singapore

2025 · Ngiap Chuan Tan, Yi Ling Eileen Koh, et al. · npj Primary Care Respiratory Medicine · 1

Increasing Burden of Tyrosine Kinase Inhibitor (TKI) Treatment Failure with Later Lines of Therapy (LOT) in Chronic Myeloid Leukemia (CML): A Real World Retrospective Database Analysis

2014 · Y.J. Chen, H. Huang, et al. · Value in Health

Works count: 6

Citation count: 46

H-index: 3

I10-index: 1